List of Excipients in API tobramycin
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing tobramycin
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Alcon Laboratories Inc | TOBREX | tobramycin | 0065-0643 | BENZALKONIUM CHLORIDE | |
| Alcon Laboratories Inc | TOBREX | tobramycin | 0065-0643 | BORIC ACID | |
| Alcon Laboratories Inc | TOBREX | tobramycin | 0065-0643 | SODIUM CHLORIDE | |
| Alcon Laboratories Inc | TOBREX | tobramycin | 0065-0643 | SODIUM HYDROXIDE | |
| Alcon Laboratories Inc | TOBREX | tobramycin | 0065-0643 | SODIUM SULFATE | |
| Alcon Laboratories Inc | TOBREX | tobramycin | 0065-0643 | SULFURIC ACID | |
| Alcon Laboratories Inc | TOBREX | tobramycin | 0065-0643 | TYLOXAPOL | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing tobramycin
Detailed excipient profiles for tobramycin
Excipient focus: 1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE
tobramycin drug variants containing 1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0630 |
| Mylan Specialty LP | tobramycin | 49502-346 |
| Mylan Specialty LP | tobramycin | 49502-401 |
| >Company | >Ingredient | >NDC |
tobramycin drug variants not containing 1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE
Excipient focus: BENZALKONIUM CHLORIDE
tobramycin drug variants containing BENZALKONIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin | 0065-0643 |
| Henry Schein Inc | tobramycin | 0404-7196 |
| Blenheim Pharmacal Inc | tobramycin | 10544-883 |
| MWI | tobramycin | 13985-604 |
| STAT Rx USA LLC | tobramycin | 16590-224 |
| Akorn | tobramycin | 17478-290 |
| Rebel Distributors Corp | tobramycin | 21695-204 |
| >Company | >Ingredient | >NDC |
tobramycin drug variants not containing BENZALKONIUM CHLORIDE
Excipient focus: BORIC ACID
tobramycin drug variants containing BORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin | 0065-0643 |
| Henry Schein Inc | tobramycin | 0404-7196 |
| Blenheim Pharmacal Inc | tobramycin | 10544-883 |
| MWI | tobramycin | 13985-604 |
| STAT Rx USA LLC | tobramycin | 16590-224 |
| Akorn | tobramycin | 17478-290 |
| Rebel Distributors Corp | tobramycin | 21695-204 |
| >Company | >Ingredient | >NDC |
tobramycin drug variants not containing BORIC ACID
Excipient focus: CALCIUM CHLORIDE
tobramycin drug variants containing CALCIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Novartis Pharmaceuticals Corporation | tobramycin | 0078-0630 |
| Mylan Specialty LP | tobramycin | 49502-346 |
| Mylan Specialty LP | tobramycin | 49502-401 |
| >Company | >Ingredient | >NDC |
tobramycin drug variants not containing CALCIUM CHLORIDE
Excipient focus: CHLOROBUTANOL
tobramycin drug variants containing CHLOROBUTANOL
tobramycin drug variants not containing CHLOROBUTANOL
Excipient focus: EDETATE DISODIUM
tobramycin drug variants containing EDETATE DISODIUM
tobramycin drug variants not containing EDETATE DISODIUM
Excipient focus: HYDROCHLORIC ACID
tobramycin drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin / dexamethasone | 0065-0652 |
| Eyevance Pharmaceuticals LLC | tobramycin / dexamethasone | 71776-035 |
| >Company | >Ingredient | >NDC |
tobramycin drug variants not containing HYDROCHLORIC ACID
Excipient focus: HYDROXYETHYL CELLULOSE
tobramycin drug variants containing HYDROXYETHYL CELLULOSE
tobramycin drug variants not containing HYDROXYETHYL CELLULOSE
Excipient focus: MINERAL OIL
tobramycin drug variants containing MINERAL OIL
tobramycin drug variants not containing MINERAL OIL
Excipient focus: NITROGEN
tobramycin drug variants containing NITROGEN
| Company | Ingredient | NDC |
|---|---|---|
| NorthStar RxLLC | tobramycin inhalation solution | 16714-119 |
| Dr Reddy's Laboratories Inc | tobramycin inhalation solution | 43598-605 |
| Sun Pharmaceutical Industries Inc | tobramycin | 47335-171 |
| American Health Packaging | tobramycin | 60687-731 |
| >Company | >Ingredient | >NDC |
tobramycin drug variants not containing NITROGEN
Excipient focus: PETROLATUM
tobramycin drug variants containing PETROLATUM
tobramycin drug variants not containing PETROLATUM
Excipient focus: PHENOL
tobramycin drug variants containing PHENOL
| Company | Ingredient | NDC |
|---|---|---|
| Baxter Healthcare Corporation | tobramycin | 36000-242 |
| Mylan Institutional LLC | tobramycin | 67457-473 |
| Akorn | tobramycin sulfate | 17478-114 |
| Fresenius Kabi USA LLC | tobramycin sulfate | 63323-306 |
| >Company | >Ingredient | >NDC |
tobramycin drug variants not containing PHENOL
Excipient focus: PROPYLENE GLYCOL
tobramycin drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin / dexamethasone | 0065-0652 |
| Eyevance Pharmaceuticals LLC | tobramycin / dexamethasone | 71776-035 |
| >Company | >Ingredient | >NDC |
tobramycin drug variants not containing PROPYLENE GLYCOL
Excipient focus: SODIUM BISULFITE
tobramycin drug variants containing SODIUM BISULFITE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Institutional LLC | tobramycin | 67457-473 |
| >Company | >Ingredient | >NDC |
tobramycin drug variants not containing SODIUM BISULFITE
Excipient focus: SODIUM CHLORIDE
tobramycin drug variants containing SODIUM CHLORIDE
tobramycin drug variants not containing SODIUM CHLORIDE
Excipient focus: SODIUM DITHIONATE
tobramycin drug variants containing SODIUM DITHIONATE
| Company | Ingredient | NDC |
|---|---|---|
| Akorn | tobramycin sulfate | 17478-114 |
| >Company | >Ingredient | >NDC |
tobramycin drug variants not containing SODIUM DITHIONATE
Excipient focus: SODIUM HYDROXIDE
tobramycin drug variants containing SODIUM HYDROXIDE
tobramycin drug variants not containing SODIUM HYDROXIDE
Excipient focus: SODIUM METABISULFITE
tobramycin drug variants containing SODIUM METABISULFITE
| Company | Ingredient | NDC |
|---|---|---|
| Hospira Inc | tobramycin | 0409-3577 |
| Baxter Healthcare Corporation | tobramycin | 36000-242 |
| Gland Pharma Limited | tobramycin | 68083-241 |
| Gland Pharma Limited | tobramycin | 68083-253 |
| Fresenius Kabi USA LLC | tobramycin sulfate | 63323-306 |
| Fresenius Kabi USA LLC | tobramycin sulfate | 63323-307 |
| >Company | >Ingredient | >NDC |
tobramycin drug variants not containing SODIUM METABISULFITE
Excipient focus: SODIUM SULFATE
tobramycin drug variants containing SODIUM SULFATE
tobramycin drug variants not containing SODIUM SULFATE
Excipient focus: SODIUM SULFATE ANHYDROUS
tobramycin drug variants containing SODIUM SULFATE ANHYDROUS
tobramycin drug variants not containing SODIUM SULFATE ANHYDROUS
Excipient focus: SULFURIC ACID
tobramycin drug variants containing SULFURIC ACID
tobramycin drug variants not containing SULFURIC ACID
Excipient focus: TRISODIUM CITRATE DIHYDRATE
tobramycin drug variants containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | tobramycin | 0093-3750 |
| >Company | >Ingredient | >NDC |
tobramycin drug variants not containing TRISODIUM CITRATE DIHYDRATE
Excipient focus: TYLOXAPOL
tobramycin drug variants containing TYLOXAPOL
tobramycin drug variants not containing TYLOXAPOL
Excipient focus: WATER
tobramycin drug variants containing WATER
tobramycin drug variants not containing WATER
Excipient focus: XANTHAN GUM
tobramycin drug variants containing XANTHAN GUM
| Company | Ingredient | NDC |
|---|---|---|
| Alcon Laboratories Inc | tobramycin / dexamethasone | 0065-0652 |
| Eyevance Pharmaceuticals LLC | tobramycin / dexamethasone | 71776-035 |
| >Company | >Ingredient | >NDC |
tobramycin drug variants not containing XANTHAN GUM
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
